Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia
Clinical trial NCT02215824 · TERMINATED
Trial details
- NCT number
- NCT02215824
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2003-10-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.